09.23.25 -- The Evolving Landscape Of Drug Discovery Services

Review studies using the NIH:OVCAR-3 model of human ovarian cancer in the subcutaneous setting in NSG mice with multiple standard agents and vehicles. This model has shown reproducible growth.

Reliable binding measurements drive research forward. Explore fluorescence techniques and optimal labeling strategies for sensitive, high-quality data crucial for discovery and cellular studies.

Discover how next-generation sequencing and digital PCR enable miRNA biomarker discovery and validation. Learn best practices for sample prep, data analysis, and assay design.

The choice of species for nonclinical safety studies is an important step in the drug development process. Check out this scientific journal which outlines vital considerations for species selection.

A recent project applied process improvement methodology to the process validation step that ultimately provided not only an optimized, robust process but also an economic advantage.

Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

Learn how a comprehensive, variant-aware screening workflow for therapeutic gene editing can identify and nominate the most favorable guide RNAs for clinical development.